Wall Street Journal - Sept 28



Sept 28 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

- Eleven of the world’s largest banks and brokerages will collectively pay $1.8 billion in fines to resolve regulatory investigations over their employees' use of messaging applications that broke record-keeping rules, regulators said Tuesday.

- Lawyers for Elon Musk and Twitter Inc TWTR.N debated several pending requests for information in their continuing legal fight, with less than three weeks to go before a scheduled trial over Musk’s soured $44 billion takeover.

- Eisai Co 4523.T and Biogen Inc BIIB.O said their experimental Alzheimer’s disease drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects for approval.

- A federal antitrust trial that could determine the fate of a partnership between American Airlines Group Inc AAL.O and JetBlue Airways Corp JBLU.O opened Tuesday with U.S. Department of Justice lawyers and the airlines trading arguments over whether the alliance would lead to higher fares.

- Car-rental company Hertz Global Holdings Inc HTZ.O and energy firm BP PLC BP.L said they signed a deal to develop and manage a network of electric-vehicle charging stations across North America.
Compiled by Bengaluru newsroom; Editing by Dhanya Ann Thoppil

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.